<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01345812</url>
  </required_header>
  <id_info>
    <org_study_id>20090169</org_study_id>
    <nct_id>NCT01345812</nct_id>
  </id_info>
  <brief_title>Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.</brief_title>
  <official_title>Time-lapse Assessed Evaluation of Embryo Development After Stimulation With Either Recombinant Follicle Stimulating Hormone (FSH) or Urine-derived Follicle Stimulating Hormone (FSH).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Fertility Clinic Braedstrup Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trianglen Fertility Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aagaard Fertility Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the investigation is to identify differences in embryo development
      after follicle stimulation with two different gonadotrophins.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      So far the assessment of the development potential of the single embryo has been limited by
      the vulnerability of the embryos when exposed to fluctuations in temperature and CO2 levels.

      Thus embryos can only be allowed to leave incubators for a very limited time period.

      However, with the development of time-lapse systems for clinical use it is possible to make
      continuous time-lapse recordings of embryos while they are in a safe incubator environment.

      The embryos are not compromised, but the entire embryonic development can still be seen, and
      will subsequently provide new and essential information on the competence of the single
      embryo.

      Based on the above it is expected that the probability of selecting the most viable and
      competent embryo is increased, which, in turn, will increase the success rate for couples
      seeking infertility treatment.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of patients for recruitment
  </why_stopped>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Top Quality Embryos day 2</measure>
    <time_frame>44 h after insemination</time_frame>
    <description>The oocytes are inseminated and loaded to the time-lapse instrument and cultured for two days. The embryo developemnt are followed at the movie and the embryos are scored according to a standard scoring criteria at 44 h after insemination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>5 weeks after embryo transfer</time_frame>
    <description>The pregnancy is verified by a blood sample two weeks after embryo transfer and the number of embryos implanted are verified by ultrasound scanning five weeks after embryo transfer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">291</enrollment>
  <condition>Patients for In Vitro Fertilization(IVF)Treatment</condition>
  <arm_group>
    <arm_group_label>urine-derived FSH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Follicle stimulating hormone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>recombinant FSH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Follicle stimulation hormone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HP-HMG</intervention_name>
    <description>100 - 300 IU for stimulation of women in ART treatment</description>
    <arm_group_label>urine-derived FSH</arm_group_label>
    <other_name>Menopure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>recombinant FSH</intervention_name>
    <description>100 -300 IU for stimulation of women in ART treatment</description>
    <arm_group_label>recombinant FSH</arm_group_label>
    <other_name>Gonal-F</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants(heterosexuals, lesbian couples and single women) must sign a document of
        informed consent

          -  Female age 21-45 years(both inclusive)

          -  Patients for IVF treatment

          -  Regular menstrual cycle 21-35 days(both inclusive)

          -  Normal FSH levels(1-15 IU/L)

          -  BMI between 18-32(both inclusive)

          -  Patients must be able to read and understand patient information in national language

        Exclusion Criteria:

        PCO

        - Endometriosis as primary diagnosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inge Agerholm, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVF clinic Braedstrup</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The fertility clinic</name>
      <address>
        <city>Braedstrup</city>
        <zip>8740</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/</url>
    <description>database</description>
  </link>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2011</study_first_submitted>
  <study_first_submitted_qc>April 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2011</study_first_posted>
  <last_update_submitted>September 13, 2012</last_update_submitted>
  <last_update_submitted_qc>September 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ART</keyword>
  <keyword>IVF</keyword>
  <keyword>Timelapse</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

